Table 2 Projected estimates associated with each scenario
From: Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda
| Baseline CD4 count | Start (Scenario A) | Wait (Scenario B) | |
|---|---|---|---|
| Life Expectancy, in years | Lowest (250–259) | 18.01 | 15.52 |
| Mean (250–350) | 20.93 | 16.96 | |
| Highest (340–350) | 23.85 | 17.38 | |
| Discounted Life Expectancy, in years | Lowest (250–259) | 13.91 | 12.41 |
| Mean (250–350) | 15.51 | 13.29 | |
| Highest (340–350) | 17.04 | 13.54 | |
| YLL | Lowest (250–259) | 1.50 | |
| Mean (250–350) | 2.23 | ||
| Highest (340–350) | 3.49 | ||
| YLD | Lowest (250–259) | −0.17 | |
| Mean (250–350) | −0.25 | ||
| Highest (340–350) | −0.39 | ||
| DALY | Lowest (250–259) | 1.33 | |
| Mean (250–350) | 1.98 | ||
| Highest (340–350) | 3.10 | ||
| Lifetime Cost, cART + Monitoring | Lowest (250–259) | $4,255 | $3,686 |
| Mean (250–350) | $4,744 | $3,885 | |
| Highest (340–350) | $5,210 | $3,870 | |
| 24 Months Hospitalization Cost | Lowest (250–259) | $45 | $254 |
| Mean (250–350) | $42 | $389 | |
| Highest (340–350) | $38 | $565 | |
| Net Cost | Lowest (250–259) | $4,300 | $3,940 |
| Mean (250–350) | $4,786 | $4,274 | |
| Highest (340–350) | $5,248 | $4,435 | |
| Cost per DALY | Lowest (250–259) | $270 | |
| Mean (250–350) | $260 | ||
| Highest (340–350) | $262 |